ATE330013T1 - Lawsonia intracellularis impfstoff - Google Patents

Lawsonia intracellularis impfstoff

Info

Publication number
ATE330013T1
ATE330013T1 AT01204919T AT01204919T ATE330013T1 AT E330013 T1 ATE330013 T1 AT E330013T1 AT 01204919 T AT01204919 T AT 01204919T AT 01204919 T AT01204919 T AT 01204919T AT E330013 T1 ATE330013 T1 AT E330013T1
Authority
AT
Austria
Prior art keywords
relates
lawsonia intracellularis
nucleic acid
detection
dna
Prior art date
Application number
AT01204919T
Other languages
English (en)
Inventor
Antonius A C Jacobs
Paul Vermeij
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of ATE330013T1 publication Critical patent/ATE330013T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01204919T 2000-12-20 2001-12-14 Lawsonia intracellularis impfstoff ATE330013T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00204660 2000-12-20

Publications (1)

Publication Number Publication Date
ATE330013T1 true ATE330013T1 (de) 2006-07-15

Family

ID=8172486

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01204919T ATE330013T1 (de) 2000-12-20 2001-12-14 Lawsonia intracellularis impfstoff
AT05104073T ATE501258T1 (de) 2000-12-20 2001-12-14 Lawsonia intracellularis impfstoff

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT05104073T ATE501258T1 (de) 2000-12-20 2001-12-14 Lawsonia intracellularis impfstoff

Country Status (12)

Country Link
US (2) US6921536B2 (de)
EP (2) EP1586646B1 (de)
JP (1) JP4237960B2 (de)
AT (2) ATE330013T1 (de)
AU (1) AU783210B2 (de)
CA (1) CA2365494A1 (de)
DE (2) DE60120621T2 (de)
DK (2) DK1586646T3 (de)
ES (2) ES2360225T3 (de)
HU (1) HUP0105379A3 (de)
PL (1) PL205964B1 (de)
PT (1) PT1219711E (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2360225T3 (es) * 2000-12-20 2011-06-02 Intervet International Bv Vacuna contra lawsonia intracellularis.
EP1514927B1 (de) 2002-05-29 2010-05-19 Yamasa Corporation Verfahren zur produktion von nucleosid-diphosphat unter verwendung von polyphosphat: amp-phosphotransferase
ATE450545T1 (de) * 2003-09-12 2009-12-15 Intervet Int Bv Impfstoff mit lawsonia intracellularis- untereinheit
KR20060134054A (ko) * 2004-01-22 2006-12-27 인터벳 인터내셔널 비.브이. 로소니아 인트라셀룰라리스 서브유닛 백신
EP1609870A1 (de) * 2004-06-24 2005-12-28 Boehringer Ingelheim Vetmedica Gmbh Methode, um Lawsonia intracellularis zu diagnostizieren
MY146476A (en) * 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis
CA2586093A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Methods for cultivating lawsonia intracellularis
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
CA2605250A1 (en) * 2005-04-18 2006-10-26 Boehringer Ingelheim Vetmedica, Inc. Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
WO2008073464A2 (en) 2006-12-11 2008-06-19 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
US8398970B2 (en) 2007-09-17 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early Lawsonia intracellularis infections
TWI449533B (zh) * 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
ES2534556T3 (es) * 2008-07-22 2015-04-24 Intervet International Bv Bacteria Lawsonia intracellularis de un nuevo serotipo, vacuna basada en esa bacteria, anticuerpos adecuados para diagnosticar el nuevo serotipo de Lawsonia intracellularis e hibridomas para producir dichos anticuerpos
KR101837768B1 (ko) 2011-05-25 2018-03-12 건국대학교 산학협력단 돼지 증식성 회장염을 진단하기 위한 단백질 및 그 응용
US20140017268A1 (en) * 2012-06-05 2014-01-16 Regents Of The University Of Minnesota Composition and Methods for Detecting or Preventing Lawsonia intracellularis Infections
WO2016124620A1 (en) 2015-02-04 2016-08-11 Intervet International B.V. A vaccine for use against subclinical lawsonia infection in a pig
JP2018504423A (ja) 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン
CN108431024A (zh) * 2015-10-16 2018-08-21 堪萨斯州立大学研究基金会 猪3型圆环病毒免疫原性组合物以及其制备和使用方法
CL2017002196A1 (es) 2017-08-30 2017-11-17 Univ De Concepción Vacuna recombinante contra enteropatía proliferativa en animales.
CN113528683A (zh) * 2021-07-09 2021-10-22 南京农业大学 一种用于检测胞内劳森菌的绝对荧光定量pcr引物对、试剂盒及检测方法
CN120559226A (zh) * 2025-06-26 2025-08-29 杭州缇牧生物科技有限公司 猪胞内劳森菌抗体检测试纸及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310993A (en) 1980-01-07 1982-01-19 Louvers & Dampers, Inc. Louver assembly
EP0473210B1 (de) 1990-07-30 1994-04-13 Akzo Nobel N.V. Rekombinantes Mareks-Krankheitsvirus
WO1993004163A1 (en) 1991-08-23 1993-03-04 Massachusetts Institute Of Technology Strain of chlamydia
US5610059A (en) * 1992-11-09 1997-03-11 University Of Arizona Etiological agent for porcine enteritis
FR2714074B1 (fr) 1993-12-20 1996-03-01 Pasteur Institut Promoteurs des gènes GRA1, GRA2, GRA5 et GRA6 de toxoplasma gondii et vecteurs d'expression comprenant lesdits promoteurs.
US5714375A (en) * 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US7022328B1 (en) * 1995-11-30 2006-04-04 Australian Pork Limited Therapeutic and diagnostic compositions
WO2000069903A1 (en) 1999-05-13 2000-11-23 Pfizer Products Inc LAWSONIA DERIVED GENE AND RELATED SodC POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
AU771376B2 (en) 1999-05-13 2004-03-18 Agriculture Victoria Services Pty Ltd Lawsonia derived gene and related FlgE polypeptides, peptides and proteins and their uses
WO2000069905A1 (en) * 1999-05-13 2000-11-23 Australian Pork Limited LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
EP1177213A4 (de) 1999-05-13 2002-08-28 Pfizer Prod Inc Von lawsonia stammendes gen und assoziierte hämolysin-polypeptide, peptide und proteine und ihre verwendungen
EP1094070A3 (de) 1999-10-22 2002-01-09 Pfizer Products Inc. Lawsonia intracellularis Proteine sowie Methoden und Materialien die diese verwenden
US6605696B1 (en) 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
ES2360225T3 (es) * 2000-12-20 2011-06-02 Intervet International Bv Vacuna contra lawsonia intracellularis.

Also Published As

Publication number Publication date
HUP0105379A2 (hu) 2003-01-28
DK1219711T3 (da) 2006-09-25
PT1219711E (pt) 2006-10-31
CA2365494A1 (en) 2002-06-20
AU783210B2 (en) 2005-10-06
EP1586646B1 (de) 2011-03-09
US20050069559A1 (en) 2005-03-31
US6921536B2 (en) 2005-07-26
HUP0105379A3 (en) 2004-07-28
DE60120621D1 (de) 2006-07-27
ES2360225T3 (es) 2011-06-02
US7491401B2 (en) 2009-02-17
ES2266090T3 (es) 2007-03-01
EP1219711A2 (de) 2002-07-03
EP1219711B1 (de) 2006-06-14
AU9737101A (en) 2002-06-27
US20050250150A1 (en) 2005-11-10
DE60120621T2 (de) 2006-12-14
EP1586646A2 (de) 2005-10-19
ATE501258T1 (de) 2011-03-15
JP2003000276A (ja) 2003-01-07
DE60144201D1 (de) 2011-04-21
JP4237960B2 (ja) 2009-03-11
PL351277A1 (en) 2002-07-01
EP1586646A3 (de) 2007-08-01
HU0105379D0 (en) 2002-02-28
PL205964B1 (pl) 2010-06-30
DK1586646T3 (da) 2011-06-27
EP1219711A3 (de) 2002-11-06

Similar Documents

Publication Publication Date Title
ATE330013T1 (de) Lawsonia intracellularis impfstoff
ATE470673T1 (de) Impfstoffe mit lawsoniaintrazellularis- untereinheit
ATE479756T1 (de) Streptococcus pneumoniae-antigene und impfstoffe
DE60139690D1 (de) Immunisierung gegen chlamydia pneumoniae
ATE406912T1 (de) Immunisierung gegen chlamydia tracheomatis
ATE380870T1 (de) Borrelia burgdorferi rekombinante genkonstrukte
ATE450545T1 (de) Impfstoff mit lawsonia intracellularis- untereinheit
WO2003058248A3 (en) Diagnostics and vaccines for mycrobacterium paratuberculosis infections
WO2003095480A3 (en) Brachyspira hyodysenteriae vaccine
WO2004007726A3 (en) Brachyspira hyodysenteriae vaccine
ATE417106T1 (de) Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon
ATE366583T1 (de) Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407
NO20081541L (no) Ny sjo-lus vaksine
ATE448245T1 (de) Piroplasmid-impfstoff
RU2223492C2 (ru) БЕЛОК, ПОЛУЧЕННЫЙ ИЗ neisseria meningitidis (ВАРИАНТЫ), ЕГО ФРАГМЕНТ, КОДИРУЮЩАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), ЗОНД, ПРАЙМЕР, КОМПОЗИЦИЯ
PT1176192E (pt) Vacina de helicobacter felis
ATE414905T1 (de) Diabetesmodell
TH62170A (th) วัคซีนเชื้อก่อโรค Lawsonia intracellularis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1219711

Country of ref document: EP